BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Biocryst Pharmaceuticals 

2190 Parkway Lake Drive

Birmingham  Alabama  35244  U.S.A.
Phone: 205-444-4600 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Affinimark Technologies Inc. 





 Company News
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding For Manufacture And Development Of BCX4430 To Treat Hemorrhagic Virus Diseases 9/18/2014 11:20:04 AM
Biocryst Pharmaceuticals (BCRX) Announces RAPIVAB™ Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting 9/8/2014 7:38:22 AM
Biocryst Pharmaceuticals (BCRX) Participates In World Health Organization Consultation On Potential Ebola Therapies 9/4/2014 9:01:10 AM
Biocryst Pharmaceuticals (BCRX) To Present At Rodman & Renshaw Conference 9/3/2014 7:56:20 AM
Biocryst Pharmaceuticals (BCRX) To Present Peramivir Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting 9/2/2014 8:08:19 AM
Biocryst Pharmaceuticals (BCRX) Expected To Jump Into Ebola Race In A Few Weeks 8/29/2014 6:17:15 AM
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of BCX4430 To Treat Hemorrhagic Fever Virus Diseases 8/13/2014 7:20:58 AM
Biocryst Pharmaceuticals (BCRX) Reports Second Quarter 2014 Financial Results 8/5/2014 7:56:35 AM
Biocryst Pharmaceuticals (BCRX) To Announce Second Quarter 2014 Financial Results August 5 7/22/2014 3:22:34 PM
Biocryst Pharmaceuticals (BCRX) Announces Exercise Of Over-Allotment Option And Completion Of Public Offering 6/3/2014 10:52:18 AM
12345678910...